Products Categories
| CAS No.: | 7447-41-8 |
|---|---|
| Name: | Lithium chloride |
| Molecular Structure: | |
|
|
|
| Formula: | ClLi |
| Molecular Weight: | 42.39 |
| Synonyms: | Lithiumchloride (6CI,8CI);Lithium monochloride;NSC327172; |
| EINECS: | 231-212-3 |
| Density: | 2.608 g/cm3 |
| Melting Point: | 605 °C(lit.) |
| Boiling Point: | 1382 °C |
| Flash Point: | -4°F |
| Solubility: | 832 g/L (20 °C) in wtaer |
| Appearance: | White powder |
| Hazard Symbols: |
 F,  Xn,  C,  Xi
|
| Risk Codes: | 11-36/38-22-36/37/38-35-10-36/37-19-63-20/21/22 |
| Safety: | 26-37/39-36/37/39-16-36-45-33-29-22 |
| Transport Information: | UN 2789 8/PG 2 |
| PSA: | 0.00000 |
| LogP: | -2.99600 |
What can I do for you?
Get Best Price
Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.
The Lithium chloride is an organic compound with the formula LiCl. The IUPAC name of this chemical is lithium chloride. With the CAS registry number 7447-41-8, it is also named as hydrochloric acid lithium salt. The product's categories are Inorganics; Lithium Compounds; Classes of Metal Compounds; Li (Lithium) Compounds; Typical Metal Compounds; ACS GradeSynthetic Reagents; Essential Chemicals; BioUltraProtein Structural Analysis; DNA&RNA Purification; Molecular Biology; Molecular Biology Reagents; Optimization ReagentsMolecular Biology; Reagents; X-Ray Crystallography; Crystal Grade Inorganics; Lithium Salts; LithiumMetal and Ceramic Science; Metal and Ceramic Science; Salts; Inorganic Salts; Lithium; Synthetic Reagents; Cell Separation (Centrifugation) MediaEssential Chemicals; Hematology and Histology; Reagent Plus; Routine Reagents; LithiumMolecular Biology; Plant Nucleic Acid Purification; ReagentsPlant Molecular Biology; Optimization Reagents; Analytical Reagents for General Use; E-L, Puriss p.a. ACS; Puriss p.a. ACS. Besides, it is a colorless crystals or powder, which should be stored in a cool, dry place.
Preparation: this chemical can be prepared by Hydrochloric acid and Hydrochloric acid. Chemical reaction is as follows:
.png){kind=small}
Uses of Lithium chloride: it is mainly used for the production of lithium metal by electrolysis of a LiCl/KCl melt at 600 °C. LiCl is also used as a brazing flux for aluminium in automobile parts. Also, in biochemical applications, it can be used to precipitate RNA from cellular extracts. Lithium chloride is also used as a flame colorant to produce dark red flames. It is used as a desiccant for drying air streams. In more specialized applications, lithium chloride finds some use in organic synthesis.
When you are using this chemical, please be cautious about it as the following:
It is highly flammable, harmful by inhalation, in contact with skin and if swallowed and may form explosive peroxides. Besides, this chemical is irritating to eyes, respiratory system and skin and can cause severe burns. It is danger of cumulative effects and May cause cancer. When you are using it, wear suitable gloves and eye/face protection, keep away from sources of ignition - No smoking, do not breathe dust and empty into drains, take precautionary measures against static discharges. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible).
You can still convert the following datas into molecular structure:
(1)SMILES: [Li+].[Cl-]
(2)InChI: InChI=1/ClH.Li/h1H;/q;+1/p-1
(3)InChIKey: KWGKDLIKAYFUFQ-REWHXWOFAB
(4)Std. InChI: InChI=1S/ClH.Li/h1H;/q;+1/p-1
(5)Std. InChIKey: KWGKDLIKAYFUFQ-UHFFFAOYSA-M
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| bird - wild | LD50 | oral | 422mg/kg (422mg/kg) | Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983. | |
| cat | LD50 | intraperitoneal | 492mg/kg (492mg/kg) | Russian Pharmacology and Toxicology Vol. 42, Pg. 9, 1979. | |
| cat | LDLo | subcutaneous | 450mg/kg (450mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| dog | LDLo | intravenous | 500mg/kg (500mg/kg) | BEHAVIORAL: FOOD INTAKE (ANIMAL) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS MUSCULOSKELETAL: OTHER CHANGES | Journal of Pharmacology and Experimental Therapeutics. Vol. 100, Pg. 429, 1950. |
| frog | LDLo | subcutaneous | 885mg/kg (885mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. | |
| guinea pig | LD50 | intraperitoneal | 624mg/kg (624mg/kg) | "Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 157, 1999. | |
| guinea pig | LDLo | subcutaneous | 620mg/kg (620mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| human | LDLo | oral | 200mg/kg/3D (200mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: MUSCLE WEAKNESS | JAMA, Journal of the American Medical Association. Vol. 139, Pg. 688, 1949. |
| human | TDLo | oral | 243mg/kg/13D (243mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR GASTROINTESTINAL: NAUSEA OR VOMITING | JAMA, Journal of the American Medical Association. Vol. 139, Pg. 688, 1949. |
| mouse | LD50 | intracrebral | 14040ug/kg (14.04mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 69, Pg. 75, 1973. |
| mouse | LD50 | intraperitoneal | 600mg/kg (600mg/kg) | Journal of Thermal Biology. Vol. 6, Pg. 87, 1981. | |
| mouse | LD50 | intravenous | 363mg/kg (363mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS BEHAVIORAL: ANTIPSYCHOTIC | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 413, 1973. |
| mouse | LD50 | oral | 1165mg/kg (1165mg/kg) | Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970. | |
| mouse | LD50 | subcutaneous | 738mg/kg (738mg/kg) | BEHAVIORAL: TREMOR MUSCULOSKELETAL: OTHER CHANGES | Acta Pharmacologica et Toxicologica. Vol. 43, Pg. 51, 1978. |
| pigeon | LDLo | subcutaneous | 513mg/kg (513mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. | |
| quail | LD50 | oral | 422mg/kg (422mg/kg) | Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983. | |
| rabbit | LD50 | oral | 800mg/kg (800mg/kg) | Farmakologiya i Toksikologiya Vol. 39, Pg. 53, 1976. | |
| rabbit | LDLo | subcutaneous | 531mg/kg (531mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| rat | LD50 | intracrebral | 4800ug/kg (4.8mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Polish Journal of Pharmacology and Pharmacy. Vol. 26, Pg. 399, 1974. |
| rat | LD50 | intraperitoneal | 514mg/kg (514mg/kg) | Personal Communication from K.P. Petersen, DAK Labs., 59 Lergravsvej, DK-2300, Copenhagen, Demark, Dec. 22, 1977Vol. 22DEC1977, | |
| rat | LD50 | intratracheal | 205mg/kg (205mg/kg) | "Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 157, 1999. | |
| rat | LD50 | oral | 526mg/kg (526mg/kg) | Acta Pharmacologica et Toxicologica. Vol. 47, Pg. 351, 1980. | |
| rat | LD50 | subcutaneous | 499mg/kg (499mg/kg) | Personal Communication from K.P. Petersen, DAK Labs., 59 Lergravsvej, DK-2300, Copenhagen, Demark, Dec. 22, 1977Vol. 22DEC1977, |
